The so called 'agenda' in no way undermines/ refutes the

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks OMO #9177
The so called 'agenda' in no way undermines/ refutes the data.

The long term effects of the Bush tax cuts DURING a time of war, and long after, are accurate, verifiable and independent of Fed policies.

Quote:
Just two policies dating from the Bush Administration — tax cuts and the wars in Iraq and Afghanistan — accounted for over $500 billion of the deficit in 2009 and will account for nearly $6 trillion in deficits in 2009 through 2019 (including associated debt-service costs of $1.4 trillion). By 2019, we estimate that these two policies will account for almost half — over $8 trillion — of the $17 trillion in debt that will be owed under current policies .[7]


And the data are not unique to the site whose agenda you question.

As near as I can tell any analysis that doesn't fit with your 'beliefs' is agenda driven.

Oh, the 'agenda' driven site left out the effects of the unfunded Medicare D Bill for this reason:

Quote:
[8] The new Medicare prescription drug benefit, enacted in 2003, also adds to deficits over this period — by over $700 billion, net of premiums from enrollees and payments from states, in 2009 through 2019 — but for reasons explained in our October 2012 paper, we cannot quantify the net budgetary effect of the Medicare Modernization Act that added the drug benefit.


The author of the piece below had no such qualms:

Quote:
Through 2012, Medicare Part D added $318 billion to the national debt (see “General Revenue” on Page 111 in the 2013 Medicare trustees report). That same report projects that Medicare Part D will add $852 billion to the debt over the next 10 years.


Quote:
Medicare Part D: Republican Budget-Busting

By Bruce Bartlett
November 19, 2013 12:01 am November 19, 2013 12:01 am 53

DESCRIPTION

bruce-bartlett.jpg

Bruce Bartlett held senior policy roles in the Reagan and George H.W. Bush administrations and served on the staffs of Representatives Jack Kemp and Ron Paul. He is the author of “The Benefit and the Burden: Tax Reform — Why We Need It and What It Will Take.”

Ten years ago this week, Republicans enacted the largest expansion of the welfare state since the creation of Medicare in 1965 by adding a huge unfunded program providing coverage for prescription drugs to the Medicare program.

For years, responsible critics had said it was a system flaw that Medicare did not pay for prescription drugs along with hospitalization and doctors’ visits. By 2003, strong bipartisan support existed for expanding Medicare to include prescription drugs.

Republicans were keen to make sure that the legislation enacted was theirs, because the Democrats were certain to include cost containment for drugs in their legislation.

It was widely believed that if the federal government used its buying power to pressure drug companies to cut drug prices, the cost of providing drugs to Medicare recipients would be substantially reduced.

But forcing down drug prices would diminish the drug companies’ profits and Republicans were adamantly opposed to that.

Consequently, despite their oft-repeated opposition to new entitlement programs, they got behind the new drug benefit, now known as Medicare Part D, and made sure there was no cost-containment provision.

George W. Bush strongly supported this effort. Looking ahead to a close re-election in 2004, he thought a new government giveaway to the elderly would increase his vote share among this group. According to exit polls, those over age 65 gave Mr. Bush only 47 percent of their vote in 2000, with 51 percent going to Al Gore.

From the beginning, Republicans decided to forgo dedicated financing for Part D. Except for trivial premiums paid by recipients, the entire cost would fall on taxpayers. Moreover, Republicans Through 2012, Medicare Part D added $318 billion to the national debt (see “General Revenue” on Page 111 in the 2013 Medicare trustees report). That same report projects that Medicare Part D will add $852 billion to the debt over the next 10 years.refused to raise the Medicare tax or cut spending to cover Part D. Hence, the deficit increased by virtually the entire cost of the program.



An important precondition to enactment of the prescription drug benefit was that it not cost more than $400 billion over the first 10 years, a figure established in the budget resolution. Any figure higher than that would have been subject to a “point of order” by a single member of the House or Senate that would probably have derailed the legislation.

Thus it was a huge problem for Republicans when the chief actuary of the Medicare system, Richard S. Foster, concluded during the summer of 2003 that Part D would actually cost $530 billion over its first 10 years. But this fact was hidden from Congress and not revealed until it was reported by The New York Times on Jan. 30, 2004 — almost two months after the bill was signed into law.

Mr. Foster later discussed in detail the pressure exerted on him by Bush administration political appointees, in particular, Thomas A. Scully, administrator of the Centers for Medicare and Medicaid Services. In a 2004 article for a professional journal, Mr. Foster said:


Congressional activity on the legislation that became the Medicare modernization act got underway in May of 2003. In June, the then-administrator of C.M.S. ordered me to cease responding directly to congressional requests for actuarial assistance. Instead, I was directed to provide the responses to him for his review, approval and ultimate disposition.

Following several vigorous discussions, the administrator made it clear that this was a direct order and that if I failed to follow it, “the consequences of insubordination are extremely severe.” I understood this statement to mean that I would be fired if I provided the requested information to Congress.

The inspector general for the Department of Health and Human Services later determined that Mr. Scully’s action was inappropriate, but by then Part D was in law and he had left government to become a lobbyist for drug companies.

The fact that Mr. Foster’s estimate and another from the Congressional Budget Office were well above the actual cost of Medicare Part D over the first 10 years is irrelevant.

The point is that the legislation was thought to cost $400 billion in 2003. An estimate of $530 billion from the Medicare actuary would have killed the legislation or possibly forced Republicans to accept cost-containment measures opposed by the pharmaceutical industry.


But that is not the end of Republican manipulation to get the prescription drug giveaway enacted. When the legislation came up for a final vote in the House of Representatives at 3 a.m. on Nov. 22, 2003, it failed after a standard 15-minute vote, with 194 for and 209 against.

Rather than accept defeat, Republican leaders simply kept the vote open while they twisted arms to get opponents to switch their votes. By 4 a.m., the legislation was still losing, 216 yeas to 218 nays, according to an excellent report in The Hill. Finally, at 5:52 a.m., the vote closed, with Republicans eking out a 220-to-215 victory.

The record indicates that the following Republicans switched their votes from nay to yea: Ernest Istook of Oklahoma, Trent Franks of Arizona, C.L. Otter of Idaho and Calvin Dooley of California. Two Democrats, Jim Marshall and David Scott, both of Georgia, also switched from nay to yea (see Page H12296 in The Congressional Record).

The record also shows that such “deficit hawks” as the current House speaker, John Boehner of Ohio; the current House majority leader, Eric Cantor of Virginia; and the current House Budget Committee chairman, Paul Ryan of Wisconsin, voted for Medicare Part D all the way. Although out of Congress, the former speaker, Newt Gingrich, wrote a commentary in The Wall Street Journal on Nov. 20, 2003, urging all Republicans to vote yes.

Tom DeLay of Texas, then House majority leader, was later criticized by the House ethics committee for bringing undue pressure on Representative Nick Smith of Michigan to switch his vote, which he did not. Mr. DeLay later told a conservative news service that those who voted against Medicare Part D took “the easy way out.”

Three days later, the Senate joined the House in supporting the legislation, which passed by a vote of 54 to 44, with 42 Republicans voting yea and 9 nay. Among those voting yea were such staunch conservatives as Mitch McConnell of Kentucky, Orrin Hatch of Utah and Rick Santorum of Pennsylvania.

When Senator Hatch was later asked why Republicans did not provide Medicare Part D with proper financing, he said, “We didn’t have the votes to pay for it.”

But at least President Bush achieved his goal. According to exit polls, he increased his share of the over-65 vote to 52 percent in 2004.


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Icahn Faces $225M Q3 Loss, But CVR Deal Shines

Updated Category News Views 30

Icahn Enterprises Stumbles in Q3, Losses Widen When a company's financial report starts with a loss, it's like stepping into a bar fight expecting cheers—you’re bound to get more than you bargained for. Icahn Enterprises L.P.'s third quarter report isn't exactly a rosy picture. We're staring down the barrel of a net loss of $225 million, a sharp contrast to the $287...

Continue Reading
Linker Vision's AI Platform Boosts Urban Planning

Updated Category News Views 72

Now, I've seen a fair share of tech rollouts claiming to change the world, but Linker Vision’s new AI platform, Linker AI Nexa, might actually be onto something real here. Revealed at the Smart City Expo World Congress 2026 in Barcelona, this isn't just another pretty interface—it’s packing some serious firepower with NVIDIA tech. Bringing Physical AI to City...

Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups

Updated Category News Views 70

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

Continue Reading
Speakeasy Dispensary Brings Medical Cannabis to Maysville

Updated Category News Views 33

New Chapter for Maysville: Speakeasy Opens Doors Normally, you'd think of medical cannabis expansions as dry numbers and policies, but with Speakeasy Dispensary making its mark in Maysville, it's not just about business; it's a service to the community. Nestled into 317 W 2nd St, this is more than a simple retail spot. It's about bringing medical options straight to the...

Continue Reading
Neera Tanden's Progressive Vision for 2027 and Beyond

Updated Category News Views 16

Neera Tanden Sets the Stage for 2027 When it comes to politics, everyone’s got their two cents, but Neera Tanden’s unpacking a whole piggy bank of progressive dreams. Set against the backdrop of a freshly reshuffled Congress post-midterms, she’s poised to dish out her roadmap for the future at the National Press Club on November 9. A Gathering of Minds This ain't...

Continue Reading
Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 89

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
M-tron Industries Gears Up for Sonoma Investor Meetings

Updated Category News Views 13

Investors ready for solid insights from M-tron The quiet whispers of impending deals and candid discussions are what really fuel the grind of stock market exchanges. Come November 16, at the Raymond James Investor-Led Sonoma Small Cap Symposium, you can bet your last nickel that M-tron Industries, Inc. (NYSE American: MPTI) will be making waves by doling out their future...

Continue Reading
BAIC FOTON Expands With New Trucks in Africa

Updated Category News Views 88

Innovation in African Mobility Amidst the sparse horizons of Port Elizabeth, South Africa, BAIC FOTON is shifting gears in a big way. They've rolled out a duo of heavy-duty trucks—the GALAXUS R5 and C5—and topped it off with the TUNLAND V PHEV plug-in hybrid pickup. On October 29, the Africa Regional Partner Conference buzzed with talk of 'Driving to Great,' signaling...

Continue Reading
DUPR Teams Up with InBody to Elevate Pickleball Fitness

Updated Category News Views 48

Well, here's a twist in the pickleball world—DUPR and InBody have struck a deal to bring top-notch body composition tech to the ever-expanding universe of pickleballers. They're merging power players from two different worlds to tap into your performance on the court and your wellness off it. Maybe I'm just jaded from too many marketing pitches, but this one could...

Continue Reading
PATEO Drives In-Car AI Forward with NVIDIA Power

Updated Category News Views 97

Revolutionizing In-Vehicle AI with Big Names Boy, driving ain't what it used to be, and PATEO's latest adventure has a lot to do about it. They've hooked up with some major players like NVIDIA and ByteDance to really shake up the in-car AI scene. We're not just talking bells and whistles, but a true reinvention trying to blend AI straight into our daily grind on the road....

Continue Reading
lass="blog__more"> More News Articles